Project title: Use of oral colchicine to prevent restenosis in the superficial femoral artery – COLSTENT Study, no. 2022/ABM/03/00046
Consortium: University Clinical Hospital in Opole (LEADER), Upper Silesian Medical Centre named after Prof. Leszek Giec of the Silesian University of Medicine in Katowice, Institute of Human Genetics of the Polish Academy of Sciences in Poznan
Funding: total project cost of 9 279 635,25 PLN, including: clinical trial cost of 6 296 584,38 PLN; cost of research tasks of the IHG PAS 2 983 050,87 PLN
Head of IHG PAS team: Associate prof. Ewa Strauss